Analyst Activity – Ladenburg Thalmann Financial Services Raises Its Price Target On Corcept Therapeutics Incorporated (NASDAQ:CORT) to

ME Staff
-
0

Analyst Ratings For Corcept Therapeutics Incorporated (NASDAQ:CORT)

Today, Ladenburg Thalmann Financial Services raised its price target on Corcept Therapeutics Incorporated (NASDAQ:CORT) to per share.

There are 1 sell rating, 3 buy ratings on the stock.

The current consensus rating on Corcept Therapeutics Incorporated (NASDAQ:CORT) is Buy (Score: 2.50) with a consensus target price of $14.25 per share, a potential 17.19% upside.

Some recent analyst ratings include

  • 12/20/2016-Janney Montgomery Scott initiated coverage with a Sell rating.

Recent Insider Trading Activity For Corcept Therapeutics Incorporated (NASDAQ:CORT)
Corcept Therapeutics Incorporated (NASDAQ:CORT) has insider ownership of 19.20% and institutional ownership of 53.52%.

  • On 7/13/2017 David L Mahoney, Director, sold 6,994 with an average share price of $12.50 per share and the total transaction amounting to $87,425.00. View SEC Filing
  • On 7/12/2017 David L Mahoney, Director, sold 6,510 with an average share price of $12.50 per share and the total transaction amounting to $81,375.00. View SEC Filing
  • On 5/4/2017 Gary Charles Robb, CFO, bought 5,600 with an average share price of $9.75 per share and the total transaction amounting to $54,600.00. View SEC Filing
  • On 3/16/2017 Patrick G. Enright, Director, sold 269,955 with an average share price of $9.94 per share and the total transaction amounting to $2,683,352.70. View SEC Filing
  • On 3/15/2017 Patrick G Enright, Director, sold 600,000 with an average share price of $10.15 per share and the total transaction amounting to $6,090,000.00. View SEC Filing
  • On 3/8/2017 Patrick G Enright, Director, sold 750,000 with an average share price of $9.75 per share and the total transaction amounting to $7,312,500.00. View SEC Filing
  • On 2/27/2017 Patrick G Enright, Director, sold 2,500,000 with an average share price of $8.81 per share and the total transaction amounting to $22,025,000.00. View SEC Filing

Recent Trading Activity for Corcept Therapeutics Incorporated (NASDAQ:CORT)
Shares of Corcept Therapeutics Incorporated closed the previous trading session at 12.42 up +0.26 2.14% with 451,578 shares trading hands.